Guideline Summary for Dextromethorphan Use in Acute Cough
Efficacy and Dose‑Response
- A meta‑analysis demonstrated that dextromethorphan effectively suppresses acute cough associated with upper respiratory infections. 1
- Cough‑count reduction is dose‑dependent: 60 mg decreases cough episodes by ≈ 50 %, 30 mg by ≈ 28 %, while low doses (7.5–15 mg) show no measurable effect. 4
Safety Profile
- Dextromethorphan exhibits a superior safety margin compared with codeine or pholcodine; the latter provide no additional efficacy but carry a markedly higher adverse‑event burden. 1
Regulatory (FDA) Indications
- The FDA labeling authorizes dextromethorphan for temporary relief of cough caused by minor throat or bronchial irritation (e.g., common cold or inhaled irritants). 2
- It is also indicated to suppress the urge to cough in order to facilitate sleep. 1
Dosing Considerations
- While 60 mg yields maximal cough‑reflex suppression, many over‑the‑counter combinations contain additional agents (e.g., paracetamol); clinicians should verify the total ingredient load before recommending higher doses. [1][2]3
Clinical Context and Non‑Pharmacologic Advice
- Acute viral cough is generally benign; pharmacologic treatment is often unnecessary, though the symptom can cause distress and morbidity. [1][2]3
- Simple home remedies such as honey and lemon constitute the most economical first‑line advice for symptom relief. [1][2]3
- Voluntary cough suppression (behavioral control) may modestly reduce cough frequency through central modulation of the cough reflex. [1][2]3